Yuchan Wang
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
RING box protein-1(RBX1), a key component of SCF E3 ligase, induced multiple myeloma cell drug-resistance though suppressing p27.
Journal: Cancer biology & therapy
Published: August 28, 2023
CAM-DR: Mechanisms, Roles and Clinical Application in Tumors.
Journal: Frontiers in cell and developmental biology
Published: April 21, 2021
β-TrCP1 promotes cell proliferation via TNF-dependent NF-κB activation in diffuse large B cell lymphoma.
Journal: Cancer biology & therapy
Published: November 17, 2019
Role of Apg-1 in HSF1 activation and bortezomib sensitivity in myeloma cells.
Journal: Experimental hematology
Published: July 28, 2019
Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM).
Journal: BMC cancer
Published: April 14, 2019
Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma.
Journal: Hematology (Amsterdam, Netherlands)
Published: June 21, 2016
DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.
Journal: Leukemia research
Published: June 06, 2016
Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma.
Journal: Experimental cell research
Published: January 18, 2016
The role of ubiquitin-specific protease 14 (USP14) in cell adhesion-mediated drug resistance (CAM-DR) of multiple myeloma cells.
Journal: European journal of haematology
Published: December 21, 2015
Last Updated: 09/26/2026